Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection

Clinico-biological Data Collection Study of Metastatic Breast Cancer

NCT03958136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

NCT00043394 ·Status: COMPLETED ·Phase: PHASE2

Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer

NCT00870168 ·Status: COMPLETED ·Phase: NA

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

NCT00031278 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)

NCT01956552 ·Status: TERMINATED ·Phase: NA

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

NCT04368468 ·Status: COMPLETED

Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer

NCT00010075 ·Status: UNKNOWN ·Phase: PHASE2

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

NCT03676257 ·Status: COMPLETED

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

NCT03599453 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis

NCT01373710 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

NCT00322517 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years

NCT01480674 ·Status: COMPLETED

A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer

NCT01998906 ·Status: COMPLETED ·Phase: PHASE3

Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival

NCT01574170 ·Status: COMPLETED ·Phase: PHASE4

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

NCT01129336 ·Status: COMPLETED ·Phase: PHASE4

Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy

NCT02403869 ·Status: COMPLETED

Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC

NCT03838367 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

NCT03424005 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Observational Study of Pertuzumab Safety in Participants With Breast Cancer

NCT02266173 ·Status: COMPLETED

A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.

NCT06839547 ·Status: NOT_YET_RECRUITING

Metabolomics Explores Biomarkers for Metastatic Breast Cancer

NCT04302415 ·Status: UNKNOWN

BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer

NCT03603197 ·Status: COMPLETED ·Phase: PHASE2

Triple Negative Breast Cancer Trial

NCT00532727 ·Status: UNKNOWN ·Phase: PHASE3

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

NCT00493636 ·Status: COMPLETED ·Phase: PHASE2

Personalised Disease Monitoring in Metastatic Breast Cancer

NCT04597580 ·Status: ACTIVE_NOT_RECRUITING